|
|
|
| |
|
Search our extensive library for information, solutions & support
|
|
|
|
|
by Editor
July 18, 2006
A recent randomized, placebo-controlled, double-blinded clinical study involving 29 diagnosed FM patients – 28 females and 1 male – concluded that supplementation over a period of eight weeks with the nutraceutical Fibronol™ offered statistically “very significant” average improvements in several key quality-of-life measures. These included sleep duration and quality, energy, and discomfort. Fibronol™ ’s primary ingredient is SEANOL-F, a polyphenol/phlorotannin extract of the brown seaweed Ecklonia cava.
Overall, 23 FM patients received daily doses of the supplement Fibronol™, and another 6 received a placebo (fake) dose. All subjects were also maintained on their current FM symptom-management regimens, which included a wide variety of prescription drugs and dietary supplements. Measures of patients’ quality of life factors, recorded at baseline, at two weeks for placebo patients, and at eight weeks, followed standard international guidelines for use in clinical trials involving FM patients.
Key Findings
At the end of eight weeks, the patients receiving Fibronol™ supplementation experienced, on average:
- 1.6 additional hours of sleep per night
- Deeper and less interrupted sleep, expressed as an 80 percent increase in sleep soundness
- Accompanied by a 71 percent increase in energy, a 30 percent reduction in fatigue, and a 33 percent reduction in perceived discomfort level.
Each of these findings is statistically very significant, in that the probability it could have occurred by chance is less than 1 in 1,000 (P = < 0.001).
By comparison, the patients in the placebo group achieved no statistically significant improvements on these measures, and were switched during the course of the study to “open label” Fibronol™ supplementation.
Additionally, six of the patients receiving the Fibronol™ supplement who had a pre-existing condition of diarrhea experienced a worsening of the condition and were dropped from the study. The researchers speculate that this may be associated with the magnesium included as a secondary ingredient of Fibronol™, which is included for support of tissue repair. No other adverse effects were identified.
Specific Measures Employed
Measures of efficacy used in the study included:
- A Pain Diary using the Visual Analogue Scale (VAS) pain score, which asks the patient to indicate intensities by marking positions on lines between two extremes.
- The Brief Pain Inventory (BPI) pain assessment questionnaire.
- The Patient Global Impression of Change (PGIC), a patient-reported periodic assessment of perception of change in their condition.
- The Medical Outcomes Study (MOS) Sleep Scale, a 12-item self-report instrument that yields a summary score on sleep problems and detail on six sleep attribute scales.
- The Multidimensional Fatigue Inventory (MFI), a 20-item self-report instrument designed to measure fatigue.
Other tests, to assess safety and identify potential adverse effects, included CBC blood serum chemistries, urinalysis, ECG, vital sign assessments, and adverse event records. All results were “normative to reduced” with the exception of increased diarrhea for the six patients with this pre-existing condition.
An abstract of the November 2005 study report, “Fibronol™ Phase 1-a Clinical Study,” by C. Palmer, PhD, et al., is available in pdf format at www.fibronol.com/fibronol_clinical_abstract.pdf
More Studies Ahead This was a very small, preliminary (Phase I-a) study. The results seem to indicate that this natural food supplement may offer many people with FM promising support for improved quality of life. But larger, longer term studies will help to test and refine these preliminary findings. Fibronol LLC, the developer of Fibronol™ and its chief ingredient SEANOL-F – 14 years in development – has indicated plans for a Phase I-b study to run for six months.
Note:Fibronol LLC products are not intended to diagnose, treat, cure or prevent any disease.
|
|
|
 |
 |
436th most popular article of 826 discussed articles
Sort by: Date
| Score
| Username
|
|
SAENOL-F
|
Posted by: debra m
Apr 30, 2009 |
|
|
I HAVE BEEN TAKING SEANOL-F FOR 3 WEEKS NOW AND I WILL ATTEST TO ITS ABILITY TO HAVE SIGNIFICAN RELIEF YO MY NERVES.
ALTHOUGH I HAVE NOT BEEN DIAGNOSED WITH FIBROMYALGIA MY NEUROSURGEON PLACED ME ON LIRICA AND CYMBALTA DUE TO THE FACT THAT I DEVELOPED IMMEDIATELY AFTER SURGERY OF A HERNIATED DISK. MY SYATIC NERVE HAD BEEN PINCHED FOR 11 MONTHS AND NOW IT HAS BEEN 6 MONTHS SINCE MY SURGERY AND I AM JUST RECEIVING PHYSICAL THEREPY. (I'M HAVING TO DEAL WITH WORKER COMP IN ALL OF THIS, THAT IS WHY THINGS ARE NOT PROGRESSING AT A NORMAL RATE OF SPEED.)
I HAD MADE THE DECISION TO TAKE MYSELF OFF FROM THE PRESCRIPTIONS OF LIRICA AND CYMBALTA, IN TURN I ASKED MY FAVORITE HEALTH FOOD STORE OWNER (GRADUATE OF HARVARD IN NUTRITION) AND SHE SUGGESTED SOMETHING THAT WAS NEW ON THE MARKET. FIBRONO AND OR FIBROBOOST.
WHAT A DIFFERENCE IT HAS MADE IN MY LIFE. MY DAMAGE IS IN THE LEFT CALF. IT WAS COMPLETELY NUMB AND THE LEFT SIDE OF MY LEFT FOOT AND LAST TWO TOES (LEFT SIDE ALSO) HAS SHOOT PAINS THAT WHERE RUNNING UP THE FOOT ALL DAY LONG. I COULD NOT SLEEP FOR LONG ON MY BACK FOR BOTH ACHILLES HEELS WHERE BOTHERED WHEN MAKING CONTACT WITH THE MATTRESS. YES, I TRIED PLACING A PILLOW UNDER MY LEGS, TO NO AVAIL FOR IT IN TURN STARTED TO ACHE IN MY SPINE WITHIN MY MUSCLES (SPASMS).
WHAT I WOULD LIKE TO KNOW IS HAS THERE BEEN STUDIES COMPLETED ON THE SIDE EFFECTS OF THAKING TO MUCH SEANOL-F? I HAVE DEVELOPED SOME COMPLICATIONS AND CUT THE DOSAGE IN HALF. I WAS TAKING BOTH OF THE ABOVE MENTIONED. EACH WAS TWO PILLS THREE TIMES A DAY. YES IT TOOK THE PAIN AWAY, HOWEVER NOW THAT I HAVE CUT IT IN HALF I STILL HAVE CONSTIPATION AT ITS WORST AND FLU LIKE SYSTOMS. NO I DO NOT HAVE THE SWINE FLU!! IN CUTTING THIS IN HALF MY PAIN IS BACK IN THE LEFT LEG AND FOOT AS WELL AS BOTH ACHILLES HEELS.
PLEASE RESPOND TO THE QUESTION OF SIDE EFFECTS.
THANK-YOU!
DEBRA MAHONEY
HOMOSASSA, FL.
|
Reply 
|
|
|
|
|
|
|
|
|
|
 |
 |
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% [more]
Dizziness on Rising - Dealing with a Common Symptom of Fibromyalgia and ME/CFS [more]
New Drug Application for sodium oxybate as fibromyalgia treatment accepted by FDA [more]
Curcumin - a Golden Gift of Nature with Benefits Still Untold [more]
Statin drug appears to weaken body’s immune defenses [more]
|
|
|
